45 related articles for article (PubMed ID: 11331280)
1. Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.
Hapke S; Kessler H; Arroyo de Prada N; Benge A; Schmitt M; Lengyel E; Reuning U
J Biol Chem; 2001 Jul; 276(28):26340-8. PubMed ID: 11331280
[TBL] [Abstract][Full Text] [Related]
2. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Montuori N; Bifulco K; Carriero MV; La Penna C; Visconte V; Alfano D; Pesapane A; Rossi FW; Salzano S; Rossi G; Ragno P
Cell Mol Life Sci; 2011 Jul; 68(14):2453-67. PubMed ID: 20972812
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Wakefield TW; Henke PK
J Thromb Haemost; 2014 Aug; 12(8):1353-63. PubMed ID: 24943740
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.
Nakatsuka E; Sawada K; Nakamura K; Yoshimura A; Kinose Y; Kodama M; Hashimoto K; Mabuchi S; Makino H; Morii E; Yamaguchi Y; Yanase T; Itai A; Morishige KI; Kimura T
Oncotarget; 2017 Oct; 8(52):89887-89902. PubMed ID: 29163796
[TBL] [Abstract][Full Text] [Related]
5. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin.
Charo IF; Nannizzi L; Smith JW; Cheresh DA
J Cell Biol; 1990 Dec; 111(6 Pt 1):2795-800. PubMed ID: 1703545
[TBL] [Abstract][Full Text] [Related]
6. Adipose-PAS interactions in the context of its localised bio-engineering potential (Review).
Nohawica M; Errachid A; Wyganowska-Swiatkowska M
Biomed Rep; 2021 Aug; 15(2):70. PubMed ID: 34276988
[TBL] [Abstract][Full Text] [Related]
7. Modulation of α
Ciregia F; Deroyer C; Cobraiville G; Plener Z; Malaise O; Gillet P; Fillet M; Malaise MG; de Seny D
Exp Mol Med; 2021 Feb; 53(2):210-222. PubMed ID: 33526813
[TBL] [Abstract][Full Text] [Related]
8. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
Rossari F; Zucchinetti C; Buda G; Orciuolo E
Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-associated dysregulated cytokines and cancer.
Wu Y; Liu Y; Dong Y; Vadgama J
Integr Cancer Sci Ther; 2016 Feb; 3(1):370-378. PubMed ID: 29930868
[TBL] [Abstract][Full Text] [Related]
10. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.
El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R
Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254
[TBL] [Abstract][Full Text] [Related]
11. Synchronized cell attachment triggered by photo-activatable adhesive ligands allows QCM-based detection of early integrin binding.
Iturri J; García-Fernández L; Reuning U; García AJ; del Campo A; Salierno MJ
Sci Rep; 2015 Mar; 5():9533. PubMed ID: 25825012
[TBL] [Abstract][Full Text] [Related]
12. Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis.
Jin G; Peng L; Zhang J; Qu L; Shou C
Oncol Lett; 2015 Apr; 9(4):1772-1778. PubMed ID: 25789040
[TBL] [Abstract][Full Text] [Related]
13. Clinical opportunities and challenges in targeting tumour dormancy.
Hensel JA; Flaig TW; Theodorescu D
Nat Rev Clin Oncol; 2013 Jan; 10(1):41-51. PubMed ID: 23183631
[TBL] [Abstract][Full Text] [Related]
14. Korean Red Ginseng Suppresses Metastasis of Human Hepatoma SK-Hep1 Cells by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase Plasminogen Activator.
Ho YL; Li KC; Chao W; Chang YS; Huang GJ
Evid Based Complement Alternat Med; 2012; 2012():965846. PubMed ID: 22570673
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion.
Shepherd TG; Mujoomdar ML; Nachtigal MW
J Ovarian Res; 2010 Feb; 3():5. PubMed ID: 20187934
[TBL] [Abstract][Full Text] [Related]
16. {beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer.
Kaur S; Kenny HA; Jagadeeswaran S; Zillhardt MR; Montag AG; Kistner E; Yamada SD; Mitra AK; Lengyel E
Am J Pathol; 2009 Nov; 175(5):2184-96. PubMed ID: 19808644
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.
Konno H; Baba M; Shoji T; Ohta M; Suzuki S; Nakamura S
Clin Exp Metastasis; 2002; 19(6):527-34. PubMed ID: 12405290
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of intercellular adhesion molecule-1 (ICAM-1) and urokinase-type plasminogen activator receptor (uPAR) is associated with tumor cell spreading in vivo.
Donadio AC; Remedi MM; Frede S; Bonacci GR; Chiabrando GA; Pistoresi-Palencia MC
Clin Exp Metastasis; 2002; 19(5):437-44. PubMed ID: 12198772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
